Axsome Therapeutics Inc (AXSM)
Healthcare
Biotechnology
211.00 $
-3.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Axsome Therapeutics Inc (AXSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -93 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.6 | -7.4 | -21 | -26 | -30 | -46 | -78 | -108 | -117 | -145 | -128 | -93 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 4.4 | 6.8 | 8.0 | 9.1 | |
| 0.4 | 0.8 | 2.0 | 2.1 | 1.8 | 6.1 | 15 | 21 | 38 | 63 | 85 | 94 | |
| 3.4 | 3.8 | 2.0 | 2.7 | -1.0 | 6.1 | 16 | 21 | 40 | – | – | – | |
| 0.5 | 0.9 | 3.8 | -0.8 | 1.5 | 15 | 0.4 | 0.3 | 24 | -28 | 34 | -23 | |
| 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.7 | 0.6 | 0.3 | 0.5 | |
| 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -54 | -0.6 | -0.3 | -0.5 | |
| – | – | 0.0 | 0.0 | – | – | – | – | 44 | – | – | – | |
| 0.0 | 46 | 0.0 | 24 | 13 | 240 | 15 | -0.2 | -0.5 | -1.8 | – | – | |
| 5.2 | 7.3 | 10 | -0.3 | -3.4 | 13 | 27 | -0.3 | 45 | 85 | -1.0 | -4.1 | |
| 5.1 | 53 | 10.0 | 24 | 10 | 252 | 42 | 11 | 285 | 331 | 58 | 101 | |
| 0.5 | 45 | -11 | -2.6 | -20 | 206 | -36 | -97 | 114 | 185 | -71 | 7.6 | |
| -4.6 | -7.5 | -21 | -26 | -30 | -46 | -79 | -109 | -117 | -146 | -129 | -94 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.